Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company has shown a continuous increase in overseas revenue contribution, with emerging business segments developing strongly. In 2024, the company achieved operating revenue of 45.478 billion yuan, a decrease of 3.39%, while the net profit attributable to the parent company was 3.520 billion yuan, an increase of 0.41% [4][5] - The overseas market accounted for 51% of total revenue in 2024, with a gross margin of 32.05%, significantly higher than the domestic average of 24.06%. The company has established 11 overseas production bases in 8 countries and regions [4][5] - The company is focusing on optimizing its industrial structure, integrating traditional and emerging industries to foster strong growth momentum [5] Financial Performance Summary - In 2024, the company reported a gross margin of 28.17%, an increase of 0.63 percentage points year-on-year, and a net profit margin of 8.81%, an increase of 0.80 percentage points year-on-year [4] - The company forecasts operating revenues of 53.111 billion yuan, 62.327 billion yuan, and 72.886 billion yuan for 2025, 2026, and 2027 respectively, with net profits projected at 5.041 billion yuan, 6.305 billion yuan, and 7.618 billion yuan for the same years [6][9] - The diluted EPS is expected to be 0.58 yuan, 0.73 yuan, and 0.88 yuan for 2025, 2026, and 2027 respectively, with corresponding P/E ratios of 13, 11, and 9 times [6][9]
中联重科(000157):海外占比持续提升,新兴业务板块发展强劲